Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 4 |
2002 | 2 |
2003 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Paradoxical worsening of tuberculosis in HIV-infected persons.
Chest. 2001 Jul;120(1):193-7. doi: 10.1378/chest.120.1.193.
Chest. 2001.
PMID: 11451837
Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses.
Sterling TR, Dorman SE, Chaisson RE, Ding L, Hackman J, Moore K, Holland SM.
Sterling TR, et al.
Clin Infect Dis. 2001 Oct 1;33(7):976-82. doi: 10.1086/322670. Epub 2001 Aug 22.
Clin Infect Dis. 2001.
PMID: 11528568
Item in Clipboard
A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates.
Fielder JF, Chaulk CP, Dalvi M, Gachuhi R, Comstock GW, Sterling TR.
Fielder JF, et al.
Int J Tuberc Lung Dis. 2002 Dec;6(12):1114-7.
Int J Tuberc Lung Dis. 2002.
PMID: 12546121
Item in Clipboard
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR, Chaisson RE, Moore RD.
Sterling TR, et al.
AIDS. 2001 Nov 23;15(17):2251-7. doi: 10.1097/00002030-200111230-00006.
AIDS. 2001.
PMID: 11698698
Item in Clipboard
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J.
Sterling TR, et al.
J Infect Dis. 2002 Oct 15;186(8):1181-5. doi: 10.1086/343807. Epub 2002 Sep 30.
J Infect Dis. 2002.
PMID: 12355373
Free article.
Item in Clipboard
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.
Sterling TR, Chaisson RE, Keruly J, Moore RD.
Sterling TR, et al.
J Infect Dis. 2003 Dec 1;188(11):1659-65. doi: 10.1086/379741. Epub 2003 Nov 14.
J Infect Dis. 2003.
PMID: 14639536
Item in Clipboard
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.
Sadaphal P, Astemborski J, Graham NM, Sheely L, Bonds M, Madison A, Vlahov D, Thomas DL, Sterling TR.
Sadaphal P, et al.
Clin Infect Dis. 2001 Nov 15;33(10):1687-91. doi: 10.1086/323896. Epub 2001 Oct 12.
Clin Infect Dis. 2001.
PMID: 11641824
Free PMC article.
Item in Clipboard
Cite
Cite